Stem Cell Umbilical Cord Blood Global Market Report 2025
상품코드:1769765
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
줄기세포 제대혈 시장 규모는 향후 몇 년간 빠르게 성장할 것으로 예상됩니다. 2024년 67억 7천만 달러에서 2025년 79억 8천만 달러로 연평균 성장률(CAGR) 17.8%로 성장할 것으로 예상됩니다. 이 기간에 예측되는 주목할만한 동향으로는 치료 응용의 진전, 헬스 케어 인프라의 개선, 동결보존 기술의 혁신, 줄기 세포 치료와 유전자 치료의 융합 등을 들 수 있습니다.
출산율의 상승은 향후 수년간 줄기세포 제대혈 시장의 성장을 견인할 것으로 예측됩니다. 출산율 증가는 주로 불임 치료가 이용하기 쉬워지고, 더 많은 가족이 임신할 수 있게 되었기 때문입니다. 이 세포는 신생아에게 유전적으로 적합하며 형제 자매와 다른 가족에게도 도움이 될 수 있습니다. 그 결과, 출산율 증가가 줄기 세포 제대혈 시장의 확대에 크게 기여하고 있습니다.
줄기세포 제대혈 시장의 주요 기업은 희소유전성 질환의 치료, 면역계의 회복 강화, 재생 의료 구상의 지원 등을 목적으로 한 제대혈 세포 요법 등 혁신적인 치료법의 개발과 승인 취득에 주력하고 있습니다. 예를 들어, 2024년 10월, 미국에 본사를 둔 생명공학 기업인 StemCyte는 Long COVID-19 증후군을 치료하기 위해 고안된 조혈 전구 세포 제대혈 요법(HPC 제대혈)에 대해 미국 식품 의약국(FDA)으로부터 재생 의료 첨단 치료의 지정을 받았습니다.
본 보고서는 강력한 성장세를 보이고 있는 줄기세포 제대혈 시장에 중점을 두고 있으며, 향후 10년 및 그 이후 시장을 형성할 트렌드에 대한 가이드를 제공합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계 줄기세포 제대혈 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계 줄기세포 제대혈 시장 : 성장률 분석
세계 줄기세포 제대혈 시장 실적 : 규모와 성장, 2019-2024년
세계 줄기세포 제대혈 시장 예측 : 규모와 성장, 2024-2029년, 2034F
세계 줄기세포 제대혈 시장 : 총 시장 규모(TAM)
제6장 시장 세분화
세계 줄기세포 제대혈 시장 : 제품 유형별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
제대혈 줄기세포
제대 조직 줄기 세포
세계 줄기세포 제대혈 시장 : 기술별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
동결보존
줄기세포 증식
세포 분리
세계 줄기세포 제대혈 시장 : 저장 서비스별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
공립 제대혈 은행
민간 제대혈 은행
하이브리드 제대혈 은행
세계 줄기세포 제대혈 시장 : 용도별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
혈액 질환
대사성 질환
면역계 질환
신경질환
기타 용도
세계 줄기세포 제대혈 시장 : 최종 사용자별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
병원
연구기관
바이오테크놀러지 기업
기타 최종 사용자
세계의 줄기세포 제대혈 시장 : 제대혈 줄기세포, 유형별 세분화 : 분석과 예측, 2019-2024년, 2024-2029F, 2034F
조혈 줄기세포
중간엽 줄기세포
내피 전구 세포
제어성 T 세포
내츄럴 킬러 세포
수지상 세포
세계의 줄기세포 제대혈 시장 : 제대조직 줄기세포, 유형별 세분화 : 분석과 예측, 2019-2024년, 2024-2029F, 2034F
중간엽 줄기세포
상피세포
섬유아세포
신경 전구 세포
제7장 지역별/국가별 분석
세계의 줄기세포 제대혈 시장 : 지역별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
세계의 줄기세포 제대혈 시장 : 국가별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
줄기세포 제대혈 시장 : 경쟁 구도
줄기세포 제대혈 시장 : 기업 프로파일
Takeda Pharmaceutical Company Limited : 개요, 제품 및 서비스, 전략 및 재무 분석
Global Cord Blood Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
Vita 34 AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Cordlife Group Limited : 개요, 제품 및 서비스, 전략 및 재무 분석
StemLife Berhad : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
MediPost Co. Ltd.
Smart Cells International Ltd.
StemCyte Inc.
Celularity Inc.
Next Biosciences Pty Ltd
Esperite NV
Cryo-Cell International Inc.
FamiCord Group
Cells4Life Group LLP
Cryoviva Biotech Pvt. Ltd.
Americord Registry LLC
ViaCord LLC
China Cord Blood Corporation
CBR Systems Inc.
Cord Blood Registry
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
줄기세포 제대혈 시장(2029년) : 새로운 기회를 제공하는 국가
줄기세포 제대혈 시장(2029년) : 새로운 기회를 제공하는 부문
줄기세포 제대혈 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
JHS
영문 목차
영문목차
Umbilical cord blood stem cells are a unique type of cells obtained from the blood left in the umbilical cord and placenta following childbirth. This blood is a rich source of hematopoietic stem cells (HSCs), which can transform into various blood cells, including red blood cells, white blood cells, and platelets. These stem cells are widely used in medical treatments such as bone marrow transplants for individuals suffering from blood-related conditions like leukemia, lymphoma, and specific genetic disorders.
The key components of umbilical cord blood stem cells include both cord blood stem cells and cord tissue stem cells. Cord blood stem cells, which are hematopoietic in nature, are collected from a newborn's umbilical cord and are utilized in treating blood and immune-related disorders. The technologies involved encompass cryopreservation, stem cell expansion, and cell separation. Storage options are divided among public cord blood banks, private cord blood banks, and hybrid models. The primary uses of stem cell umbilical cord blood span across hematologic diseases, metabolic disorders, immune deficiencies, neurological conditions, and more, catering to end-users such as hospitals, research centers, biotech firms, and others.
The stem cell umbilical cord blood market research report is one of a series of new reports from The Business Research Company that provides stem cell umbilical cord blood market statistics, including stem cell umbilical cord blood industry global market size, regional shares, competitors with a stem cell umbilical cord blood market share, detailed stem cell umbilical cord blood market segments, market trends and opportunities, and any further data you may need to thrive in the stem cell umbilical cord blood industry. This stem cell umbilical cord blood market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The stem cell umbilical cord blood market size has grown rapidly in recent years. It will grow from $6.77 billion in 2024 to $7.98 billion in 2025 at a compound annual growth rate (CAGR) of 17.8%. This growth during the historical period can be credited to rising investments in research and development, heightened demand for private cord blood banking, a surge in clinical trial activities, a growing number of cancer cases, and an increase in fertility clinics worldwide.
The stem cell umbilical cord blood market size is expected to see rapid growth in the next few years. It will grow to $15.21 billion in 2029 at a compound annual growth rate (CAGR) of 17.5%. Factors contributing to this anticipated growth include the escalating incidence of chronic diseases, higher birth rates, growing interest in stem cell-based therapies, supportive governmental policies, and increasing emphasis on regenerative medicine. Noteworthy trends projected for this period include progress in therapeutic applications, improvements in healthcare infrastructure, innovations in cryopreservation technology, and the fusion of stem cell treatments with gene therapy advancements.
The rising childbirth rates are anticipated to drive the growth of the stem cell umbilical cord blood market in the coming years. Childbirth rates refer to the number of live births per 1,000 individuals in a population over a specific period, typically one year. The growth in childbirth rates is primarily attributed to the increased availability and affordability of fertility treatments, allowing more families to conceive. Umbilical cord blood stem cells are particularly valuable for newborns because they contain hematopoietic stem cells, which are instrumental in treating a range of blood, immune, and genetic disorders. These cells are genetically matched to the infant and may also be beneficial for siblings or other family members. For example, in April 2025, the U.S. Centers for Disease Control and Prevention reported that the number of births in the United States rose from 3,596,017 in 2023 to 3,622,673 in 2024, marking a 1% increase. As a result, the growing childbirth rates are significantly contributing to the expansion of the stem cell umbilical cord blood market.
Leading companies in the stem cell umbilical cord blood market are concentrating on developing innovative therapies and securing approvals, such as cord blood cell therapy for treating rare genetic disorders, enhancing immune system recovery, and supporting regenerative medicine initiatives. Cord blood cell therapy involves using stem cells obtained from umbilical cord blood to treat various medical conditions by regenerating or repairing damaged blood, immune, and tissue systems. For instance, in October 2024, StemCyte, a biotechnology company based in the United States, received regenerative medicine advanced therapy designation from the U.S. Food and Drug Administration (FDA) for its hematopoietic progenitor cell cord blood therapy (HPC Cord Blood) designed to treat Long COVID-19 syndrome. This cord blood cell therapy leverages umbilical cord stem cells to aid in healing and reduce inflammation. It has demonstrated promise in treating immune-related and degenerative disorders and offers a non-invasive, ethically sourced alternative for advanced regenerative therapies.
In July 2023, Leukaemia & Myeloma Research UK, a stem cell therapies organization based in the United Kingdom, partnered with Smart Cells International to offer funded storage of cord blood stem cells. This collaboration is intended to give families a secure and efficient method for collecting and preserving umbilical cord blood stem cells for future medical applications and research purposes. Smart Cells International, also headquartered in the UK, specializes in the collection and storage of umbilical cord blood stem cells.
Major players in the stem cell umbilical cord blood market are Takeda Pharmaceutical Company Limited, Global Cord Blood Corporation, Vita 34 AG, Cordlife Group Limited, StemLife Berhad, MediPost Co. Ltd., Smart Cells International Ltd., StemCyte Inc., Celularity Inc., Next Biosciences Pty Ltd, Esperite N.V., Cryo-Cell International Inc., FamiCord Group, Cells4Life Group LLP, Cryoviva Biotech Pvt. Ltd., Americord Registry LLC, ViaCord LLC, China Cord Blood Corporation, CBR Systems Inc., Cord Blood Registry.
North America was the largest region in the stem cell umbilical cord blood market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in stem umbilical cord blood report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the stem umbilical cord blood market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The stem umbilical cord blood market consists of revenues earned by entities by providing services such as collection services, processing, testing, cryopreservation, storage, and transportation of cord blood, as well as related genetic screening and stem cell banking services. The market value includes the value of related goods sold by the service provider or included within the service offering. The stem umbilical cord blood market also includes sales of whole cord blood units, isolated stem cell products, and cord blood expansion kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Stem Cell Umbilical Cord Blood Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on stem cell umbilical cord blood market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for stem cell umbilical cord blood ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The stem cell umbilical cord blood market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
3. Stem Cell Umbilical Cord Blood Market Trends And Strategies
4. Stem Cell Umbilical Cord Blood Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Stem Cell Umbilical Cord Blood Growth Analysis And Strategic Analysis Framework
5.1. Global Stem Cell Umbilical Cord Blood PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
